COVID-19 Research Support

Comments · 418 Views

We are actively cooperating with researchers and third-party platforms engaged in COVID-19 research and treatment development.

We will continue to provide high-quality products, services, consultation and a high level of responsiveness to support the research and development of new coronaviruses worldwide.

Our Technology

Our beat antisense expert is ambitious, grow fast, and are committed to providing the best siRNA drug development services. We have an impeccable track record of helping customers with sirna rna drug design and in vivo delivery.

Products and Services

DNA/RNA Synthesis Reagents

Oligo can be used for targeted gene therapy. It’s necessary to analyze and purify the Oligo after synthesis to get high purity products for drug discovery or biomedical research.

About the Oligo Drug Development Services

As an RNAi effector molecule, siRNA regulates the expression of eukaryotic genes at the most important level of genomic function, including chromatin structure, RNA processing/stabilization…

siRNA

The drug delivery system has become an effective tool for transporting drug candidates in vivo. It can not only provide drug stability but also be targeted.

Drug Delivery System

Prevention and treatment of human diseases can be achieved by delivering mRNA encoding disease-specific antigens into the body.

Science Advisor

We collaborate with Shiyue Fang’s group from Michigan Technological University on sensitive DNA/RNA synthesis.

Science Advisor: Prof Shiyue Fang

  • Postdoctoral in Nucleic Acid Chemistry, Purdue University (2001-2004)
  • Ph.D. in Organic Chemistry from University of Missouri-St. Louis (2001)
  • M.S. degree in Organic Chemistry from Chinese Academy of Sciences (1994)
Dr. Fang’s research interests are in the areas of organic chemistry and nucleic acid chemistry. Current projects in his research group include developing methodologies for sensitive DNA and RNA synthesis, and total chemical gene synthesis. The projects have been supported by the National Science Foundation and National Institutes of Health. Dr. Fang has published more than 50 research articles in various international journals including three invited book chapters. He has been awarded three patents by US PTO.
Comments